These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24998519)

  • 1. Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.
    Eggermont LJ; Paulis LE; Tel J; Figdor CG
    Trends Biotechnol; 2014 Sep; 32(9):456-65. PubMed ID: 24998519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
    Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
    Hickey JW; Vicente FP; Howard GP; Mao HQ; Schneck JP
    Nano Lett; 2017 Nov; 17(11):7045-7054. PubMed ID: 28994285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
    Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
    Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro.
    Han H; Peng JR; Chen PC; Gong L; Qiao SS; Wang WZ; Cui ZQ; Yu X; Wei YH; Leng XS
    Biochem Biophys Res Commun; 2011 Aug; 411(3):530-5. PubMed ID: 21756876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Engineered Lymphocyte-Based Homologous Targeting Artificial Antigen-Presenting Cells for Personalized Cancer Immunotherapy.
    Sun L; Shen F; Xiong Z; Yang H; Dong Z; Xiang J; Gu Q; Ji Q; Fan C; Liu Z
    J Am Chem Soc; 2022 May; 144(17):7634-7645. PubMed ID: 35438987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.
    Hou F; Guo Z; Ho MT; Hui Y; Zhao CX
    ACS Nano; 2024 Mar; 18(12):8571-8599. PubMed ID: 38483840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial antigen-presenting cells for use in adoptive immunotherapy.
    Turtle CJ; Riddell SR
    Cancer J; 2010; 16(4):374-81. PubMed ID: 20693850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes.
    Shao J; Xu Q; Su S; Wei J; Meng F; Chen F; Zhao Y; Du J; Zou Z; Qian X; Liu B
    Cell Immunol; 2018 Dec; 334():78-86. PubMed ID: 30392890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Antigen-Presenting Cells for Immunotherapies.
    Siefert AL; Fahmy TM; Kim D
    Methods Mol Biol; 2017; 1530():343-353. PubMed ID: 28150213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
    Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
    Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells.
    Majedi FS; Hasani-Sadrabadi MM; Thauland TJ; Li S; Bouchard LS; Butte MJ
    Nano Lett; 2019 Oct; 19(10):6945-6954. PubMed ID: 31478664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.
    Li H; Shao S; Cai J; Burner D; Lu L; Chen Q; Minev B; Ma W
    Immunology; 2017 Nov; 152(3):462-471. PubMed ID: 28664991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
    Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
    Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Tumor Metastasis by Artificial Antigen-Presenting Cells via Targeted Microenvironment Regulation and T-Cell Activation.
    Lu Y; Li L; Du J; Chen J; Xu X; Yang X; Ding C; Mao C
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55890-55901. PubMed ID: 34787393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
    Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
    Front Immunol; 2021; 12():674276. PubMed ID: 34566953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
    Sunshine JC; Perica K; Schneck JP; Green JJ
    Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth.
    Shen C; Cheng K; Miao S; Wang W; He Y; Meng F; Zhang J
    Immunol Lett; 2013 Feb; 150(1-2):1-11. PubMed ID: 23328744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.